Study guide
14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up
AMCB Certified Nurse-Midwife CNM
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care
1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral
2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts
2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy
3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy
3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy
4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss
4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care
5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance
5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion
6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation
6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy
7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair
7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture
8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation
8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications
9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage
9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation
10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health
10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis
11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination
11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes
12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days
12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days
13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization
13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening
14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation
14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral
15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders
15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome
16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause
16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis
17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions
17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking
18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity
18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care
14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up
Key Takeaways Explain This Topic AI
Medication abortion uses mifepristone 200 mg orally followed 24 to 48 hours later by misoprostol 800 mcg buccally, with 95 to 98 percent efficacy through 70 days of gestation.
ACOG's 2024 clinical practice update suggests forgoing routine Rh testing and RhD immune globulin for abortion or pregnancy loss before 12 0/7 weeks.
Urgent warning signs after medication abortion are soaking two maxi pads per hour for two consecutive hours, fever above 38 degrees Celsius persisting more than 24 hours after misoprostol, or severe unrelieved pain.
Completion can be confirmed by an 80 percent or greater hCG decline at 7 days, ultrasound, or a high-sensitivity urine pregnancy test at 4 weeks; routine in-person follow-up is not required.
The strongest predictor of psychological distress after abortion is a pre-existing mental health condition, and the Turnaway Study found worse outcomes among those denied a wanted abortion.
Last updated: September 2026
Options Counseling
The blueprint asks the midwife to provide options counseling for pregnancy, including continuation and termination , to refer for services to electively terminate pregnancy , to prescribe medication to electively terminate pregnancy , and to assess need for and facilitate socioemotional follow-up after termination . Scope of practice varies, but the counseling competency does not.
Non-directive counseling means presenting parenting, adoption, and abortion neutrally, in the patient's preferred language, without inserting the clinician's own values. Practical steps:
Confirm the pregnancy and establish gestational age by last menstrual period plus ultrasound when dating is uncertain — options and timing depend on it.
Ask an open question — "How are you feeling about being pregnant?" — before offering any information.
Screen for coercion , from a partner, family, or anyone else, and for intimate partner violence.
Give accurate, balanced information about each option, including adoption types (open, semi-open, closed) and who provides each service.
Document the discussion and the patient's decision , and make the referral concrete — a name, number, and appointment, not a pamphlet.
Important
Know your state. Since Dobbs v. Jackson Women's Health Organization (2022), abortion legality, gestational limits, mandatory waiting periods, and even what a clinician may lawfully say or refer for vary enormously by state. The midwife is responsible for knowing the current law where they are licensed, and for knowing which nearby jurisdictions and telehealth services are available to patients when local care is unavailable.
Medication Abortion
Regimen (combined, preferred):
Mifepristone 200 mg orally — a progesterone-receptor antagonist that detaches the decidua and sensitizes the myometrium — followed 24 to 48 hours later by
Misoprostol 800 mcg buccally (vaginal and sublingual routes are also used), a prostaglandin E1 analogue producing cervical softening and uterine contractions.
Efficacy and limits: approximately 95–98% complete through 70 days (10 weeks) of gestation, the FDA-labeled limit; ACOG supports evidence-based use through 11 weeks. A repeat misoprostol dose may be given if the pregnancy has not passed.
Misoprostol-alone regimens (800 mcg sublingually or vaginally every 3 hours for up to three doses) are used where mifepristone is unavailable and are less effective, roughly 78–93%.
What to tell the patient to expect: cramping and bleeding beginning 1 to 4 hours after misoprostol, heavier than a period, with clots, tapering over 1 to 2 weeks. Ibuprofen is more effective than acetaminophen and does not reduce efficacy.
When to call urgently: soaking two maxi pads per hour for two consecutive hours , fever above 38 °C persisting beyond 24 hours after misoprostol, severe pain unrelieved by analgesia, or foul-smelling discharge.
Contraindications: confirmed or suspected ectopic pregnancy , an IUD in place (remove first), chronic adrenal failure, long-term corticosteroid therapy, inherited porphyria, coagulopathy or current anticoagulation, and mifepristone or misoprostol allergy.
Note
RhD immune globulin update. ACOG's 2024 Clinical Practice Update and an SMFM statement now suggest forgoing routine Rh testing and RhD immune globulin for abortion or pregnancy loss at less than 12 0/7 weeks , because the likelihood of alloimmunization at that gestational age is very low. This reverses the long-standing practice of giving a 50 mcg mini-dose. Follow current institutional and state protocol, and be ready to explain the change.
Procedural Abortion
Uterine aspiration (manual or electric vacuum aspiration) is used in the first trimester and into the early second trimester, typically under paracervical block with or without sedation. It is a brief procedure with a very high completion rate.
Dilation and evacuation (D&E) is the second-trimester method, usually preceded by osmotic dilators (laminaria or Dilapan-S) or pharmacologic preparation.
Overall safety: the major complication rate for abortion is well under 1% , and the mortality rate is substantially lower than that of childbirth . This is a fact patients frequently have wrong and are entitled to hear accurately.
Follow-Up and Confirming Completion
Routine in-person follow-up is not required after uncomplicated medication abortion. Completion is confirmed by any of:
Serum hCG decline of at least 80% at 7 days after mifepristone;
Ultrasound showing an empty uterus (note that a thick endometrial stripe alone is not an indication for intervention);
A high-sensitivity urine pregnancy test at 4 weeks , or a low-sensitivity ("multi-level") test earlier;
Patient-reported symptom checklists, which perform well in studies.
Contraception starts immediately. All methods can be initiated the same day, including an IUD placed at the time of aspiration or once completion of a medication abortion is confirmed. Ovulation can resume within 2 to 3 weeks .
Socioemotional Follow-Up
The most common emotional response is relief. The strongest predictor of psychological distress after abortion is a pre-existing mental health condition , not the abortion itself.
The Turnaway Study followed people who obtained abortions and those turned away for being past a facility's gestational limit: those denied a wanted abortion had worse mental health in the short term and worse financial, physical health, and family outcomes years later.
"Post-abortion syndrome" is not a recognized psychiatric diagnosis and should not be presented as one.
Some patients do grieve, especially after a wanted pregnancy ended for fetal or maternal indication. Ask rather than assume : "How are you feeling about the decision now?"
Screen for depression and anxiety, offer peer and professional support (All-Options talkline, Exhale, perinatal mental health providers), and revisit at the contraception or well-woman visit.
Do not disclose the abortion in records or conversations beyond what care requires, and be aware of the legal-privacy environment in your state.